AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glybir 1 Tablet

Prescription Icon
Prescription Required

Marketer

Brilliant Lifesciences Pvt Ltd

Salt Composition

Glimepiride (1mg)

Overview Glybir 1 Tablet

Diabex-1, a sulfonylurea-class medication, manages type 2 diabetes in adults. It regulates blood glucose, mitigating severe diabetic complications like renal failure and vision impairment. Diabex-1 can be prescribed alone or in conjunction with other treatments. Administer just before or with the morning meal, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may adjust based on glucose readings. Continue Diabex-1 therapy even with controlled blood sugar; abrupt cessation, without medical supervision, elevates the risk of complications, including nephropathy, blindness, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan incorporating diet, exercise, and weight control as directed by your healthcare provider. Lifestyle significantly influences diabetes control. Common adverse effects include hypoglycemia, nausea, headache, fatigue, and vertigo. Learn to identify hypoglycemia symptoms (sweating, dizziness, headache, tremor) and appropriate countermeasures. Maintain regular meals and carry readily available glucose sources (sugary foods or juice). Alcohol consumption increases hypoglycemia risk and should be limited. Weight gain may occur. Diabex-1 is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Inform your doctor of prior heart, thyroid, or endocrine disorders before commencing treatment, as suitability may vary. Pregnant or lactating women should consult their physician prior to use. Regular blood glucose monitoring and periodic blood tests (blood cell count, liver function) are recommended.

Uses of Glybir 1 Tablet

Managing type 2 diabetes

Major Benefits of Glybir 1 Tablet:

Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glybir 1 Tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.

Common Side effects of Glybir 1 Tablet:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Nausea
  • Dizziness
  • Weakness

How to use Glybir 1 Tablet:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the Glybir 1 Tablet whole; avoid chewing, crushing, or fracturing it. It should be taken with food.

How Glybir 1 Tablet works:

One Glybir tablet functions as an anti-diabetic agent, stimulating pancreatic insulin secretion to reduce blood sugar levels.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Avoid alcohol while taking Glybir 1 Tablet.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glybir 1 Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential benefits against any risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Glybir 1 Tablet while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a risk to the infant. Close observation of the nursing infant's blood sugar levels is recommended if the mother is taking Glybir 1 Tablet.

DrivingDrivingCAUTION

Driving may be impaired by excessively high or low blood sugar levels. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glybir 1 Tablet cautiously, potentially requiring dosage modification. Consult a physician before use. Glybir 1 Tablet is contraindicated in patients with severe kidney disease due to the risk of significantly low blood glucose, which may eventually resolve.

LiverLiverCAUTION

Exercise caution when administering Glybir 1 Tablet to individuals with hepatic impairment; dosage modification may be necessary. Physician consultation is advised. Glybir 1 Tablet is contraindicated in patients exhibiting severe liver disease due to the potential for significant hypoglycemia, which may resolve only after an extended period.

What if you forget to take Glybir 1 Tablet :

Omit the forgotten Glybir 1 Tablet dose and continue with your regular dosing schedule.

Facts to Know About Glybir 1 Tablet

LabelValue
Pharmaceutical Classification Third-generation sulfonylurea agent
Potential for Dependence None.
Medication Category Diabetes medication

FAQs on Glybir 1 Tablet

Initiate Glybir 1 Tablet therapy with 1 mg or 2 mg once daily, taken with breakfast. Individuals with increased hypoglycemia risk (such as the elderly or those with kidney dysfunction) should begin with 1 mg daily. The typical maintenance dosage ranges from 1 to 4 mg daily. The highest recommended daily dose is 8 mg. Following a 2 mg daily dose, subsequent increases should not exceed 2 mg and should be spaced 1 to 2 weeks apart, guided by blood glucose monitoring.
Glybir 1 Tablet is not inherently somniferous. Nevertheless, concomitant use with other antidiabetic medications can induce hypoglycemia, potentially resulting in drowsiness or sleep disturbances.
Glybir 1 Tablet poses no renal risk for individuals with healthy kidneys. Nevertheless, its administration is contraindicated in patients exhibiting severe renal impairment due to its primary renal excretion.
Glybir 1 Tablet has not been linked to memory impairment. Nevertheless, its use can lead to hypoglycemia, potentially resulting in impaired concentration and reduced mental acuity.
Glybir 1 Tablet is contraindicated for individuals with hypersensitivity to its components, severe hepatic or renal impairment, glucose-6-phosphate dehydrogenase deficiency, or those scheduled for surgical procedures. Furthermore, its use should be avoided by women attempting conception, pregnant women, breastfeeding mothers, and patients with insulin-dependent diabetes (type 1 diabetes mellitus).
One Glybir tablet typically lowers blood glucose within two to three hours. You might not notice any immediate changes, however, this doesn't indicate ineffectiveness. Continue your prescribed dosage, and consult your physician with any questions or worries.
Diabetes management typically requires ongoing treatment, often lifelong. Glybir 1 Tablet manages blood sugar levels but doesn't provide a cure. Discontinuing Glybir 1 Tablet should only occur under a doctor's supervision; abrupt cessation may exacerbate the condition.
Take Glybir 1 Tablet only as your physician directs. Exceeding the prescribed dose of Glybir 1 Tablet can drastically lower your blood glucose (causing hypoglycemia). Should you suspect an overdose and notice a drop in your blood sugar, ingest a quick-acting sugar source (such as sugar cubes, sugary juice, or sweetened beverage) and contact a doctor at once. Serious hypoglycemic episodes, including unconsciousness or coma, necessitate urgent medical intervention and hospitalization.
Glybir 1 Tablet should not be ingested on an empty stomach, as this may lead to dangerously low blood sugar. Symptoms of hypoglycemia include dizziness, tremor, nervousness, impatience, tachycardia, and disorientation. Consequently, administer this medication with breakfast or your first meal. Omit the dose if you are foregoing a meal.
Glybir 1 Tablet use may result in weight increase. This sulfonylurea medication prompts insulin release from the pancreas, potentially increasing appetite and leading to modest weight gain in certain individuals. Maintaining a balanced diet and regular physical activity is recommended to manage weight.
Glybir 1 Tablet may induce dizziness. Should this occur, rest by sitting or lying down until the sensation subsides. To manage dizziness during travel, it's advisable to keep a readily available source of sugar, such as sweets or fruit juice, on hand.
To maintain good health, it's best to limit dietary saturated and trans fats, opting instead for the healthy fats found in fish and nuts. Managing carbohydrate consumption is also crucial, as it significantly impacts blood glucose levels.
Glybir 1 Tablet is generally safe under a physician's guidance. Nevertheless, adverse reactions are possible. Optimal efficacy requires consistent daily dosing at the prescribed amount.
Diabetics need to incorporate protein, alongside other vital nutrients, in their daily meals. Protein is a significant energy source amongst essential nutrients; it serves as a fundamental building block for the body and metabolizes into glucose, releasing energy. This glucose release from protein is considerably slower than that from carbohydrates. Consequently, a rise in blood glucose levels typically occurs hours after high-protein food intake.
Artificial sweeteners aren't beneficial for individuals with diabetes. Their chemical composition can trigger a range of adverse reactions, from mild to serious. Therefore, minimizing or eliminating their consumption is advisable.
Indeed, poorly managed diabetes significantly increases the risk of kidney failure. Prolonged, uncontrolled blood sugar levels damage the kidneys, resulting in diabetic nephropathy. This kidney disease is a leading cause of renal failure among diabetics. Protecting kidney health requires diligent diabetes management, including dietary adjustments, consistent blood glucose monitoring, regular blood testing, and timely medication adherence.
High blood sugar characterizes diabetes, a condition that, if unmanaged, can severely impact the heart, brain, kidneys, and eyes. Nevertheless, through dietary adjustments, lifestyle modifications, and appropriate medication, individuals can effectively control their diabetes and maintain a healthy existence.
Glybir 1 Tablet
30
MRP 35
14% off